Entrada Therapeutics, Inc. (TRDA)
10.81
+0.22
(+2.08%)
USD |
NASDAQ |
Dec 11, 16:00
10.82
+0.01
(+0.09%)
Pre-Market: 20:00
Entrada Therapeutics Free Cash Flow: -129.80M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Janux Therapeutics, Inc. | -71.40M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
| Oragenics, Inc. | -8.429M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -28.31M |
| Cash from Investing (Quarterly) | 49.11M |
| Cash from Financing (Quarterly) | 0.008M |
| Free Cash Flow Per Share (Quarterly) | -0.6787 |
| Free Cash Flow to Equity (Quarterly) | -25.80M |
| Free Cash Flow to Firm (Quarterly) | -28.14M |
| Free Cash Flow Yield | -28.77% |